Chennai
08042781449
+918248517214

Therapeutic Inertia #bestdiabetologistinperambur #bestcardiologistinkolathur

Therapeutic inertia (TI) is the failure of health care providers to initiate or intensify treatment when patient's therapeutic goals are not met, common in managing chronic conditions like diabetes and hypertension. It causes significant treatment delays, often exceeding one year, leading to prolonged suboptimal control and increased risk of complications

Key Aspects of Therapeutic Inertia
  • Definition: Defined as a lack of timely adjustment to therapy when treatment targets (e.g., HbA1c, blood pressure) are not met, according to guidelines.
  • Causes: Factors contributing to TI include provider reluctance (e.g., fear of hypoglycemia, overestimation of care quality), patient factors (e.g., complexity of treatment, treatment fatigue), and system-level barriers.
  • Impact: It leads to poorer health outcomes, including increased cardiovascular risk and accelerated microvascular complications, particularly in Type 2 diabetes.
  • Distinction from Clinical Inertia: While sometimes used interchangeably, TI often specifically refers to medication adjustments, whereas "clinical inertia" is a broader term encompassing all aspects of failing to act, including lack of screening or lifestyle intervention.
  • Overcoming TI: Strategies include team-based care, using structured, evidence-based guidelines, implementing prompt systems, and shared decision-making
 2026-04-07T13:47:04

Keywords